[Cardiac Rehabilitation]

Die Rehabilitation
|December 14, 2022
PubMed

Insights

Cardiac rehabilitation (CR) significantly reduces mortality after acute coronary syndrome and coronary bypass grafting. For heart failure patients, CR improves exercise capacity and quality of life, highlighting its crucial role in cardiovascular care.

Area of Science:

  • Cardiology
  • Rehabilitation Medicine
  • Public Health

Context:

  • Cardiac rehabilitation (CR) guidelines require updating and harmonization across German-speaking European countries.
  • CR encompasses indications, content, and delivery methods for diverse cardiovascular patient populations.

Purpose:

  • To develop a scientific guideline for exercise-based CR, updating and harmonizing practices in German-speaking Europe.
  • To evaluate the prognostic effects of CR post-acute coronary syndrome (ACS), coronary bypass grafting (CABG), and in heart failure with reduced ejection fraction (HFrEF).
  • To assess the impact of psychological interventions (PI) within CR and establish recommendations through a formal consensus process.

Summary:

  • CR significantly reduces all-cause mortality in ACS and CABG patients.
  • HFrEF patients experience improved exercise capacity and quality of life with CR.
  • Evidence suggests benefits for other conditions like heart valve surgery, congenital heart disease, and peripheral arterial disease, though clarity varies.
  • Treatment intensity, including supervision, risk factor management, education, and adapted exercise volume, is crucial for CR efficacy.
  • Psychological interventions, particularly distress management and lifestyle changes, show positive trends.
  • Patient education enhances knowledge, motivation, and behavior change (physical activity, diet, smoking cessation).
  • Diversity-sensitive approaches are needed for special patient groups and gender considerations.

Impact:

  • This guideline reinforces the significant benefits of CR for specific cardiac indications.
  • It highlights the minimum therapeutic requirements for effective CR delivery.
  • The updated recommendations aim to standardize and improve CR practices for better patient outcomes.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
25
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
31
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.0K